The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share Price (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Physiomics Plc Ord 0.4p

Physiomics is listed in the FTSE AIM All-Share index.

Physiomics is listed in the Medical Services sector.

Physiomics Plc Ord 0.4p is listed on the London Stock Exchange trading with ticker code PYC.L. It has a market capitalisation of £1.76m, with approximately 135.47m shares in issue. Over the last year, Physiomics share price has been traded in a range of 2.175, hitting a high of 3.10, and a low of 0.925.

Physiomics Share Price
Price 1.30
Bid 0.00
Ask 0.00
Change 0.00 (0.00%)
Volume 0
Open 0.00
High 0.00
Low 0.00
Prev. Close 1.30
Currency GBX
Issue Country GB
Shares in Issue 135.47m
Market Capitalisation £1.76m
Market Size 75,000
52 Week High 3.10
52 Week High Date 25-Sep-2023
52 Week Low 0.925
52 Week Low Date 09-Aug-2023
# Trades 0
Vol. Sold 0
Sold Value £N/A
Vol. Bought 0
Bought Value £N/A
PE Ratio -2.653061
Earnings -0.49
Dividend 0.00
Yield 0.00%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Physiomics (PYC)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
  • No trades found.

Directors Deals for Physiomics (PYC)

Announced Traded Action Notifier Price Currency Amount Holding
25-Jul-2322-Jul-23Transfer ToJames Simon Millen held the position of Executive Chairman at the time of this trade.James Simon Millen0.00500,0001,884,393
18-Jul-2314-Jul-23Transfer ToChristophe Chassagnole held the position of COO at the time of this trade.Christophe Chassagnole0.00500,0001,102,723
29-Jun-2128-Jun-21Transfer ToChristophe Chassagnole held the position of COO at the time of this trade.Christophe Chassagnole0.0085,715602,723
21-May-2121-May-21Transfer ToJames Simon Millen held the position of CEO at the time of this trade.James Simon Millen0.00242,2871,384,393
22-Mar-2129-Jan-21Transfer ToJames Simon Millen held the position of CEO at the time of this trade.James Simon Millen0.00242,2871,384,393
Physiomics

Physiomics is a leading oncology drug development consultancy using proprietary state of the artVirtual Tumourâ„¢ technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help them save time and money during pre-clinical and clinical development.

Physiomics Home Page

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.